Jinhe Biotechnology Co.Ltd(002688) (SZ Jinhe Biotechnology Co.Ltd(002688) , closing price: 5.19 yuan) released the annual performance report on April 21, saying that the operating revenue in 2021 was about 2.078 billion yuan, an increase of 14.51% year-on-year; The net profit attributable to the shareholders of the listed company was about 93.99 million yuan, a year-on-year decrease of 19.89%; The basic earnings per share was 0.14 yuan, a year-on-year decrease of 22.22%. It is proposed not to distribute cash, give bonus shares or convert to growth.
From January to June 2021, Jinhe Biotechnology Co.Ltd(002688) ‘s operating revenue was composed of: veterinary chemicals accounted for 51.06%, Shenzhen Agricultural Products Group Co.Ltd(000061) processing industry accounted for 24.1%, veterinary biological products accounted for 16.73%, environmental protection business accounted for 3.58% and others accounted for 3.29%.
Jinhe Biotechnology Co.Ltd(002688) ‘s chairman is Wang Dongxiao, male, 70 years old, with a master’s degree background; The general manager is Xie Changxian, male, 60 years old, with a master’s degree background.
